General Ultrasound in Massachusetts

Ontact Health Co., Ltd. develops SONIX Health, an FDA-cleared (510(k) K240645) AI-powered echocardiography analysis workstation designed to automate cardiac ultrasound interpretation and measurement. The solution performs fully automated analysis of 81 diagnostic parameters with 98% image recognition accuracy and 91% measurement accuracy, eliminating the need for ECG input by automatically detecting heart cycles via valve motion analysis. SONIX Health operates as vendor-neutral software compatible with multi-vendor echocardiography equipment, deployable on-premise or cloud-based without requiring high-specification hardware. The platform streamlines workflow through one-touch analysis from imaging to report generation, reducing clinician workload and examination wait times while supporting training applications. The company emphasizes clinical validation through peer-reviewed publications in cardiovascular imaging journals and demonstrated deployment in hospital environments across multiple geographies. Target markets include cardiac diagnostic centers, hospital ultrasound departments, and training programs seeking to standardize and accelerate echocardiographic assessment.

Butterfly Network manufactures and distributes the iQ3, a handheld, whole-body portable ultrasound probe for point-of-care ultrasound (POCUS) applications. The iQ3 integrates advanced AI-powered diagnostic capabilities, workflow management software, and a comprehensive education suite to enable clinicians across emergency medicine, primary care, obstetrics, and specialty practices to perform real-time ultrasound assessments at the bedside or point of care. The company serves individual practitioners, health systems, hospitals, and medical education institutions. Products include the iQ3 probe (FDA-cleared), with an established installed base of 145,000+ customers globally. The iQ3 represents an upgrade path from earlier Butterfly models (iQ, iQ+); trade-in programs are offered. Key software platform: Compass AI, a POCUS management module designed to centralize ultrasound workflows across health systems. Clinical applications include obstetric gestational age assessment, lung ultrasound (B-line detection), cardiac evaluation, and emergency diagnostic imaging. The company publishes clinical evidence demonstrating impact on patient outcomes, including reduced length of stay and improved charge capture in hospital deployments. Regulatory credentials include FDA 510(k) clearance. The platform emphasizes ease of use, portability, and seamless integration into clinical workflows for both resource-constrained and academic medical environments.

Echosens is a pioneer in non-invasive liver health assessment, headquartered in Westborough, Massachusetts. The company manufactures and distributes FibroScan®, the global reference standard for liver fibrosis and liver steatosis assessment. FibroScan® uses Vibration-Controlled Transient Elastography (VCTE) technology to enable non-invasive, painless evaluation of liver disease without biopsy. With over 6,500 systems installed worldwide across 127+ countries, Echosens has facilitated millions of liver examinations. The technology is supported by over 6,270 peer-reviewed publications and recognition in 250+ international clinical guidelines. Echosens offers multiple product lines: the FibroScan® Family (including FibroScan® Mini, a portable variant); Guided VCTE™ (next-generation assessment platform); Liver Health Management (LHM), a cloud-based solution for comprehensive liver disease monitoring; and Scores solutions that integrate biological markers with FibroScan® data. The company serves hepatology, gastroenterology, infectious disease, primary care, and occupational health settings. Echosens manufactures devices with uniform algorithms designed to minimize inter-operator variability and eliminate inter-system variability, supporting evidence-based clinical decision-making. The company operates a global distribution network and provides trade-in programs for equipment upgrades.

Terason, a division of Teratech Corporation, is a global leader in portable ultrasound imaging systems founded in 1994. Based in Burlington, Massachusetts, Terason pioneered the first patented color portable ultrasound and specializes in ultrasound-guided venous intervention. The company's uSmart platform delivers high-performance micro-miniaturized ultrasound systems designed for diverse clinical settings including hospitals, outpatient centers, and point-of-care environments. Key product lines include the uSmart 3300 NexGen and uSmart 3200T NexGen systems, both recognized for superior image quality and reliability across multiple medical specialties. Terason's technology portfolio features advanced capabilities such as Enhanced Needle Visualization (ENV), TeraVision II imaging, TeraScape panoramic imaging, Smart Gestures control, capacitive touch interfaces, and open architecture integration with DICOM standards. The company emphasizes comprehensive clinical education and real-time technical support through its uConnect service, alongside partnerships with major organizations like Siemens and Brainlab.

UltraSight is an Israeli digital health company specializing in AI-powered cardiac ultrasound imaging software. The platform provides real-time guidance and quality assessment to enable healthcare professionals of any sonography proficiency level to consistently perform high-quality cardiac ultrasound acquisitions at the point of care—in clinics, community hospitals, ambulances, and remote/rural areas. The software integrates with ultrasound devices (including Philips Lumify) and complies with healthcare standards (HL7, DICOM). UltraSight has achieved FDA clearance and CE Mark certification. The solution addresses critical clinical needs in emergency medicine, out-of-hospital care, critical care monitoring, and resource-limited settings, democratizing access to cardiac imaging while improving diagnostic accuracy and reducing repeat procedures. Clinical evidence demonstrates that novice users achieve diagnostic-quality images approaching expert sonographer performance following minimal training.